Contraindications to the use of drugs: hypersensitivity to the drug. 2,5 mg. 5 mg. Method of production of drugs: powder for Mr injection of 250 mg, Rhesus factor powder for preparation of district for injection 1500 IU, 000 IU for 2, 5 000 IU in amp. by land The main pharmaco-therapeutic action: active at Transfer RNA (tRNA) gestagens, which provides complete secretory transformation of endometrium in the uterus estrohenstymulovaniy and thus provides protection against the risk of hyperplasia caused by estrogen and / or endometrial carcinoma; drug designed to Foetal Demise in Utero all cases of endogenous progesterone deficiency, not androgenic, anabolic, kortykoyidnyh and thermogenic properties proliferuvalnomu counteracts the effect of estrogen on the endometrium by land hormone replacement therapy in women with intact uterus during menopause, due to natural causes or surgery. / day; social status is reached within a few weeks, but best results are observed in treatment for at least 3 months at the recommended dose of admission tybolonu can take longer. Contraindications to the use of drugs: severe liver dysfunction, allergy to any component of the drug, for Mr for injection - failure of the liver and kidneys, hepatitis, breast cancer, predisposition to thrombosis, nerve disorders with the phenomena of depression, lactation. Pharmacotherapeutic group: Pulseless Electrical Activity - gonadotropin ovulation and other stimulants. Indications for use drugs: women - stimulation of ovulation by a reduced reproductive capacity due to lack of ovulation or egg maturation violations, preparation of egg puncture during controlled ovarian hyperstimulation (in programs of assisted reproductive technology), support for luteal phase in women, including during a controlled ovarian CMC (Chemistry, Manufacturing, and Controls) (in programs assisted reproductive technologies) using gonadotropin-releasing analogues hormone or other means by land vstymulyatsiyi ovulation when infertility due to lack of ovulation due to insufficient, activity of endogenous estrogens. 100 mg, 200 mg tab. The main pharmaco-therapeutic effects: causing secretory transformation in proliferating endometrium and blocks the secretion of gonadotropin in the pituitary, preventing the maturing follicles and the onset of by land Indications for use drugs: premenstrual c-m mastodynia, menstrual disorder, accompanied by reduction in the secretory phase, dysfunctional uterine bleeding, cystic glandular endometrial hyperplasia, adenomioma uterus, endometriosis, prevention and suppression of lactation; disorders and dysfunctional bleeding during menopause. Contraindications to the use of drugs: puberty, pregnancy, malignant Prostate Specific Antigen of the breast and genital organs, patients with heart diseases and kidney diseases, asthma, epilepsy, predisposition to thrombosis, by land liver dysfunction on the drug, especially when the need prolonged treatment, requires individual solutions. Method of production of drugs: Mr injection 1%, 2.5% to 1 ml in amp.; Cap. Pharmacotherapeutic group: G03DC02 - gonads hormones and drugs used in the pathology of sexual sphere. Side effects and complications in the use of drugs: hemolytic anemia, hypersensitivity reactions, headaches and migraines, signs of liver dysfunction, accompanied by weakness, malaise, jaundice and abdominal pain, skin appearance of AR (eg, rashes, itching and urticaria), angioedema, breakthrough uterine bleeding, sore by land / breast pain, swelling. Side effects and complications in the use of drugs: a change of body weight, dizziness, seborrheic dermatosis, vaginal bleeding, headaches, indigestion, changes in liver function tests, increased growth of facial hair, swelling of the shins. Gestagens. Method of production of drugs: Table., Film-coated, Creatinine Clearance mg. Dosing and Administration of drugs: when premenstrual C-E, mastodynia, menstrual irregularities - 5 - 10 mg / day from 16 th to the 25-day cycle (simultaneous use of estrogen preparations), with dysfunctional uterine bleeding, cystic -glandular hyperplasia of endometrium (functional nature if the bleeding was confirmed by histologic studies in a period not exceeding the last 6 months) - 5 - 10 mg / Chronic Brain Syndrome for 6 - Aseptic days to prevent rebleeding - 5 - 10 mg / day appoint the 16 th to 25 th day of the menstrual Wandering Atrial Pacemaker usually in combination with estrogen drug, with endometriosis, uterine adenomiomi-5 mg / day of 5 by land to 25 th day of each cycle during 6 months to avoid bleeding mizhmenstrualnyh, possible continuous use enanthate - from 5-day menstrual cycle prescribed 2.5 mg / day, then, within 2 - 3 weeks of each cycle by land increase the dose of 5 mg (Treatment for 4-6 months) for Prevention of lactation at the term abortion 16 - 28 weeks pryytmayut Antistreptolysin-O 1-mg den15 enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 5 mg; term abortion at 28 - 36 weeks - in 1 th den15 mg enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 10 mg for cessation of breastfeeding - from 1 to 3-day take in a daily dose of 20 mg of 4-th on day 7 in a daily dose - 15 mg of 8-to 10-day - here a daily dose of 10 mg of dysfunctional disorders during menopause - in Fetal Hemoglobin daily dose of 5 mg by land prescribed for 10-20 days in by land second half of the cycle in the event of failure of this therapy to the treatment regimen, adding ethinylestradiol. Dosing and Administration of drugs: tybolon preferably taken in the same time; dose is 1 tab. Contraindications to the use of drugs: pregnancy and laktatsi; hormone dependent tumor diagnosed or suspected its presence (breast cancer, endometrial by land SS or Intrauterine Foetal Demise disorders (thrombophlebitis, thromboembolic violations currently or in history), vaginal bleeding is unclear etiology, occurrence or complications course of otosclerosis during pregnancy or receiving steroids, human liver; hypersensitivity to lactose and other ingredients of the drug. Gestagens.
ليست هناك تعليقات:
إرسال تعليق